Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity
- 1 June 2025
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (6) , 1024-1034
Abstract
BACKGROUND: Sympathetic deactivation represents a major goal of antihypertensive drug treatment. However, whether treatment normalizes the hypertension-related sympathetic cardiovascular overdrive remains uncertain. METHODS: In 219 middle-aged essential hypertensives, we analyzed, along with office systolic and diastolic blood pressure (BP) and heart rate, muscle sympathetic nerve traffic (MSNA, microneurography) before and after 3-month treatment, either as monotherapy or as combination. Controls were represented by 100 age-matched normotensives. RESULTS: Treatment caused, along with a small heart rate decrease, a clear BP reduction (from 160.5/95.5 to 142.3/85.0 mm Hg, P P <0.01). A similar pattern was detected in patients under monotherapy (n=81) or combination drug treatment (n=138). MSNA was significantly related to systolic BP before and during treatment but unrelated to heart rate. In treated patients achieving the lower BP (135.1/84.5 mm Hg, n=90), the MSNA reduction was greater than that detected in patients with the higher on-treatment BP (146.7/87.4 mm Hg, n=129). However, even in patients achieving a BP target <140/90 mm Hg, MSNA remained markedly higher (on average +66.4%) compared with controls. This was the case even when treated BP was <130/80 mm Hg. Data were similar for different antihypertensive drug classes. CONCLUSIONS: Thus, antihypertensive treatment, even when effective in achieving BP control, fails to restore the level of normotension-related MSNA, with a persistence of the pattern of heightened sympathetic influences typical of untreated patients with hypertension. Failure of normalization may contribute to the development of the residual cardiovascular risk reported in treated hypertensives.Keywords
This publication has 50 references indexed in Scilit:
- Validity of the Berlin questionnaire in detecting obstructive sleep apnea: A systematic review and meta-analysisSleep Medicine Reviews, 2017
- Differential effects of enalapril–felodipine versus enalapril–lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertensionJournal of the American Society of Hypertension, 2016
- Metabolic syndrome: a sympathetic disease?The Lancet Diabetes & Endocrinology, 2015
- Increased muscle sympathetic nerve activity predicts mortality in heart failure patientsInternational Journal of Cardiology, 2009
- The role of cardiac autonomic function in hypertension and cardiovascular diseaseCurrent Hypertension Reports, 2009
- The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE StudyAmerican Journal of Hypertension, 2001
- Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failureEuropean Heart Journal, 2001
- Sympathoexcitatory responses to the acute blood pressure fall induced by central or peripheral antihypertensive drugsAmerican Journal of Hypertension, 2000
- Differential Activation of Cardiac and Peripheral Sympathetic Nervous System by Nifedipine: Role of PharmacokineticsJACC, 1997
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984